Urological research, Malmö

141 – 150 of 183

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/organization/v1000568?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
14
15
16
17
…
19
next »

2006
Mark Advances in Biomarkers for Prostate Diseases
Abrahamsson, Per-Anders ^LU ; Canto, E.I. ; Chinnaiyan, A.M. ; Djavan, B. ; Laxman, B. ; Ogawa, O. ; Slawin, K. ; Tomlins, S.A. and Yu, S (2006) p.85-85
- Chapter in Book/Report/Conference proceeding › Book chapter
Mark The role of PSA kinetics in the management of prostate cancer
Abrahamsson, Per-Anders ^LU (2006) In European Renal & Genito-Urinary Disease p.65-66
- Contribution to journal › Article
Mark Octreotide scintigraphy and Chromogranin A do not predict clinical response in patients with octreotide acetate-treated hormone-refractory prostate cancer
Kalkner, Karl Mikael ; Acosta, Stefan ^LU ; Thorsson, Ola ^LU ; Frederiksen, Hans ^LU ; Nilsson, A ; Gustavsson, Bengt ; Elingsbo, Marie ; Stridsberg, M and Abrahamsson, Per-Anders ^LU (2006) In Prostate Cancer and Prostatic Diseases 9(1). p.92-98
- Contribution to journal › Article
2005
Mark Risks and benefits of hormonal manipulation as monotherapy or adjuvant treatment in localised prostate cancer.
Abrahamsson, Per-Anders ^LU ; Anderson, J ; Boccon-Gibod, L ; Schulman, C ; Studer, U E and Wirth, M (2005) In European Urology 48(6). p.900-905
- Contribution to journal › Scientific review
Mark Expression of Serotonin Receptors 2B and 4 in Human Prostate Cancer Tissue and Effects of Their Antagonists on Prostate Cancer Cell Lines.
Dizeyi, Nishtman ^LU ; Bjartell, Anders ^LU ; Hedlund, Petter ^LU ; Taskén, K A ; Gadaleanu, V and Abrahamsson, Per-Anders ^LU (2005) In European Urology 47(6). p.895-900
- Contribution to journal › Article
Mark The 5alpha-Reductase Type II A49T and V89L High-Activity Allelic Variants are More Common in Men with Prostate Cancer Compared with the General Population.
Giwercman, Yvonne ^LU ; Abrahamsson, Per-Anders ^LU ; Giwercman, Aleksander ^LU ; Gadaleanu, Virgil and Ahlgren, Göran ^LU (2005) In European Urology 48(Jul 20). p.679-685
- Contribution to journal › Article
Mark Neuroendocrine differentiation in prostate cancer: Implications for new treatment modalities
Vashchenko, N and Abrahamsson, Per-Anders ^LU (2005) In European Urology 47(2). p.147-155
- Contribution to journal › Scientific review
Mark Prognostic value of serum markers for prostate cancer
Stenman, UH ; Abrahamsson, Per-Anders ^LU ; Aus, G ; Lilja, H ; Bangma, C ; Hamdy, FC ; Boccon-Gibod, L and Ekman, P (2005) In Scandinavian Journal of Urology and Nephrology 39. p.64-81
- Contribution to journal › Article
Mark Epididymal and accessory sex gland function and semen quality
Elzanaty, Saad ^LU (2005)
- Thesis › Doctoral thesis (compilation)
Mark Role of somatostatin receptors in prostate carcinoma
Ceder, Jens ^LU (2005) 2. p.387-387
- Chapter in Book/Report/Conference proceeding › Book chapter

« previous
1
…
14
15
16
17
…
19
next »